+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inheritance analysis confirms compound heterozygosity of mutations in lysyl hydroxylase gene from a patient with Ehlers-Danlos syndrome type IV



Inheritance analysis confirms compound heterozygosity of mutations in lysyl hydroxylase gene from a patient with Ehlers-Danlos syndrome type IV



Journal of Investigative Dermatology 102(4): 575




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031940315

Download citation: RISBibTeXText


Related references

Compound heterozygosity for a nonsense mutation and an exon deletion in the lysyl hydroxylase gene of a patient with Ehlers Danlos syndrome type VI. Matrix Biology 15(3): 185, 1996

A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for mutations in the lysyl hydroxylase gene. Journal of Clinical Investigation 93(4): 1716-1721, 1994

Compound heterozygosity for a nonsense mutation and an exon deletion in the lysyl hydroxylase gene is associated with decreased mRNA accumulation in a patient with Ehlers Danlos syndrome type VI. Journal of Investigative Dermatology 108(4): 645, 1997

A patient with Ehlers-Danlos syndrome type VI is a compound heterozygote for the lysyl hydroxylase gene. Journal of Investigative Dermatology 101(3): 391, 1993

A null-mutated lysyl hydroxylase gene in a compound heterozygote British patient with Ehlers-Danlos syndrome type VI. Human Mutation 14(4): 351, 1999

Normal and shortened transcripts from the lysyl hydroxylase gene may explain lysyl hydroxylase deficiency in fibroblasts from a patient with Ehlers Danlos syndrome type VI. Journal of Investigative Dermatology 106(4): 907, 1996

A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene. Human Mutation 11(1): 55-61, 1998

Human lysyl hydroxylase. cDNA cloning, chromosomal assignment, regulation of gene expression and analysis of mutations in patients with type VIA Ehlers-Danlos syndrome. Acta Universitatis Ouluensis Series A Scientiae Rerum Naturalium 0(252): 1-60, 1994

Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Molecular Genetics and Metabolism 71(1-2): 212-224, 2000

Two commonly occurring mutations in the lysyl hydroxylase 1 gene decrease enzyme levels and are a primary cause of Ehlers-Danlos syndrome type VIA. Journal of Investigative Dermatology 117(2): 515, 2001

A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine. Archives of Biochemistry and Biophysics 347(1): 126-131, 1997

Lysyl hydroxylase activity and mRNA are significantly up-regulated by administration of hydralazine and ascorbate to fibroblasts from Ehlers Danlos syndrome type VI patients with a common duplication in the lysyl hydroxylase gene. Journal of Investigative Dermatology 106(4): 822, 1996

Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome. American Journal of Human Genetics 55(5): 899-906, 1994

A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene. Molecular Genetics and Metabolism 67(1): 74-82, 1999

Mutations in the lysyl hydroxylase gene are responsible for LH deficiency in eight patients with Ehlers Danlos Type VI. Journal of Dermatological Science 16(SUPPL 1): S141, 1998